PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Cost analysis • Cost analysis of valve replacement procedures PART 07: Market segmentation by product • Global mechanical heart valves market • Global tissue heart valves market • Global transcatheter heart valves market PART 08: Geographical segmentation • Heart valves market in Americas • Heart valves market in EMEA • Heart valves market in APAC PART 09: Market drivers • Incidence of heart valve diseases • Implementation of minimally invasive procedures • Use of transcatheter valve replacement technology • Rise in older population PART 10: Impact of drivers PART 11: Market challenges • Risk of potential complications • Lack of skilled personnel • Expensive heart valve replacement procedures • Stringent regulatory framework PART 12: Impact of drivers and challenges PART 13: Market trends • Focus on US • Increase in M&A • Use of stentless tissue valves • Development of novel heart valves PART 14: Vendor landscape • Competitive scenario • Market share analysis 2015 • Key vendors • Other prominent vendors PART 15: Appendix • List of abbreviations PART 16: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Global heart valves market 2015-2020 ($ billions) Exhibit 03: Five forces analysis Exhibit 04: Cost comparison of heart valve replacement procedures (high-risk group) Exhibit 05: Global heart valves market segmentation by product Exhibit 06: Global heart valves market segmentation by product 2015 Exhibit 07: Global heart valves market segmentation by product 2020 Exhibit 08: Global heart valves market segmentation by product 2015-2020 Exhibit 09: Global mechanical heart valves market segmentation by type Exhibit 10: Characteristics of mechanical valves Exhibit 11: Global mechanical heart valves market 2015-2020 ($ millions) Exhibit 12: Global tissue heart valves market segmentation by type 2015 Exhibit 13: Global tissue heart valves market 2015-2020 ($ billion) Exhibit 14: Global transcatheter heart valves market by type 2015 Exhibit 15: Global transcatheter heart valves market 2015-2020 ($ billions) Exhibit 16: Global heart valves market segmentation by geography 2015 Exhibit 17: Global heart valves market segmentation by geography 2020 Exhibit 18: Global heart valves market segmentation by geography 2015-2020 Exhibit 19: Heart valves market in Americas 2015-2020 ($ billions) Exhibit 20: Heart valves market in EMEA 2015-2020 ($ billions) Exhibit 21: Heart valves market in APAC 2015-2020 ($ billions) Exhibit 22: Impact of drivers Exhibit 23: Impact of drivers and challenges Exhibit 24: Major acquisitions 2015 Exhibit 25: Ranking of top vendors in global tissue heart valves market 2015 Exhibit 26: Ranking of top vendors in global tissue heart valves market 2015 Exhibit 27: Ranking of top vendors in global tissue heart valves market 2015 Exhibit 28: Edwards Lifesciences: Business segmentation by revenue 2015 Exhibit 29: Edwards Lifesciences: Business segmentation by revenue 2014 and 2015 ($ millions) Exhibit 30: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment 2013-2015 ($ millions) Exhibit 31: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment in US 2013-2015 ($ millions) Exhibit 32: Edwards Lifesciences: Revenue and YoY growth of transcatheter heart valve therapy segment in ROW 2013-2015 ($ millions) Exhibit 33: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment 2013-2015 ($ millions) Exhibit 34: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment in US 2013-2015 ($ millions) Exhibit 35: Edwards Lifesciences: Revenue and YoY growth of surgical heart valve therapy segment in ROW 2013-2015 ($ millions) Exhibit 36: Edwards Lifesciences: Key takeaways Exhibit 37: LivaNova: Revenue of cardiac surgery segment by geography 2015 Exhibit 38: LivoNova: Key takeaways Exhibit 39: Medtronic: Product portfolio Exhibit 40: Medtronic: Product segmentation by revenue 2015 Exhibit 41: Medtronic: Key takeaways Exhibit 42: St. Jude Medical: Product portfolio Exhibit 43: St. Jude Medical: Revenue and YoY growth of structural heart segment 2013-2015 ($ millions) Exhibit 44: St. Jude Medical: Key takeaways Exhibit 45: Other prominent vendors

Edwards Lifesciences, LivaNova, Medtronic, St. Jude Medical, Abbott Laboratories, Braile Biomedica, Cardious, Colibri Heart Valve, corlife OHG, JenaValve Technology, Lepu Medical Technology (Beijing), Meril Life Sciences, Neovasc, ON-X Life Technologies, Pulmonx, Roskardioinvest, SYMETIS.